WallStreetZenWallStreetZen

NYSEMKT: TOVX
Theriva Biologics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Theriva Biologics earnings were -$25.2M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest TOVX earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$3.5M, down 19.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, TOVX reported annual earnings of -$25.2M, with -1.6% growth.

TOVX earnings history

Current Revenue
$0.0
Current Earnings
-$25.2M
Current Profit Margin
0%

TOVX Return on Equity

Current Company
-209.4%
Current Industry
-10.3%
Current Market
29.6%
TOVX's Return on Equity (-209.4%)... subscribe to Premium to read more.
High Return on Equity Performance

TOVX Return on Assets

Current Company
-73.7%
Current Industry
-7%
TOVX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when TOVX announces earnings.

TOVX Return on Capital Employed

Current Company
-84.11%
Current Industry
-1.2%
TOVX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TOVX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
TOVX-$23.11M-$25.25MN/A-$2.08
APRE-$13.23M-$12.60MN/A-$1.93
PCSA-$13.49M-$13.56MN/A-$10.36
ERNA-$13.84M-$14.10MN/A-$2.24
ICU-$13.90M-$13.67MN/A-$12.50
View Top Biotech Stocks

Theriva Biologics Earnings Reports & History FAQ

What were Theriva Biologics's earnings last quarter?

Theriva Biologics (NYSEMKT: TOVX) reported Q4 2025 earnings per share (EPS) of $1.30, up 76.1% year over year. Total TOVX earnings for the quarter were -$3.51 million. In the same quarter last year, Theriva Biologics's earnings per share (EPS) was $5.44.

If you're new to stock investing, here's how to buy Theriva Biologics stock.

Is Theriva Biologics profitable or losing money?

As of the last Theriva Biologics earnings report, Theriva Biologics is currently losing money. Theriva Biologics's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$23.74 million, a 7.46% decrease year over year.

What was TOVX's earnings growth in the past year?

As of Theriva Biologics's earnings date in Q1 2026, Theriva Biologics's earnings has grown year over year. TOVX earnings in the past year totalled -$25.25 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.